Immunosuppressant drugs and poor kidney function increases the risk of developing different types of cancer in patients with kidney failure. A new study suggests the need for persistent cancer screening and prevention in these patients.
People with kidney failure are at increased risk of developing different types of cancer, which might be due to a variety of factors related to their disease and the treatments they receive. Often these patients undergo intervals of dialysis followed by transplantation, and then they return to dialysis if the transplant fails.
Radiofrequency Ablation (RFA) of Kidney Tumors
Radiofrequency ablation (RFA) is a medical procedure that uses electrical energy and heat to destroy cancer cells. Know more about the benefits and risks of RFA.
Advertisement
‘The risk of developing kidney and thyroid cancer is high when a patient with kidney failure is on dialysis.’
Tweet it Now
Understanding how these different exposures correspond to cancer risk can help inform cancer prevention and screening decisions for patients and can provide insights into the underlying causes of cancer.
To investigate, Elizabeth Yanik, PhD, ScM (National Cancer Institute) and her colleagues evaluated information on 202,195 kidney transplant candidates and recipients by linking the Scientific Registry of Transplant Recipients to various US population-based cancer registries.
![Renal Cell Carcinoma]( "Renal Cell Carcinoma")
Renal cell carcinoma is kidney cancer that affects the lining of the kidney tubules. The initial stages of the cancer are asymptomatic and this makes early management of the disease difficult.
For a number of cancers, the team observed clear patterns of risk that corresponded to different treatment intervals. For example, risk of kidney and thyroid cancers was high across all intervals, but the risk was particularly heightened when individuals were on dialysis.
Conversely, risk of non-Hodgkin lymphoma, melanoma, lung cancer, and certain skin cancers was highest following kidney transplantation and—for those who experienced it— prior to transplant failure. This may have been due to the effects of immunosuppressant medications that are needed while living with a functioning kidney transplant.
These findings reveal that kidney dysfunction and immunosuppressant medications can have important effects on cancer incidence in patients with kidney failure.
"Our study indicates that the needs of individuals with end-stage renal disease, in terms of cancer prevention and cancer screening, will likely differ over time," said Dr. Yanik. "Vigilance for kidney cancer and thyroid cancer may be of particular importance while these individuals are on dialysis. Extra consideration for screening for melanoma or lung cancer may be called for while taking immunosuppressant medications following a kidney transplant."
In an accompanying editorial, Wai Lim, PhD (University of Western Australia) and Steven Chadban, PhD (University of Sydney) noted that "the epidemiologic insights provided by Yanik et al. may have important implications for the pathogenesis and mechanism of cancer development in patients."
The study will be published in an upcoming issue of the Journal of the American Society of Nephrology (JASN).
Source: Newswise
Renal Cell Carcinoma
Renal cell carcinoma is kidney cancer that affects the lining of the kidney tubules. The initial stages of the cancer are asymptomatic and this makes early management of the disease difficult.
Advertisement
For a number of cancers, the team observed clear patterns of risk that corresponded to different treatment intervals. For example, risk of kidney and thyroid cancers was high across all intervals, but the risk was particularly heightened when individuals were on dialysis.
Conversely, risk of non-Hodgkin lymphoma, melanoma, lung cancer, and certain skin cancers was highest following kidney transplantation and—for those who experienced it— prior to transplant failure. This may have been due to the effects of immunosuppressant medications that are needed while living with a functioning kidney transplant.
These findings reveal that kidney dysfunction and immunosuppressant medications can have important effects on cancer incidence in patients with kidney failure.
"Our study indicates that the needs of individuals with end-stage renal disease, in terms of cancer prevention and cancer screening, will likely differ over time," said Dr. Yanik. "Vigilance for kidney cancer and thyroid cancer may be of particular importance while these individuals are on dialysis. Extra consideration for screening for melanoma or lung cancer may be called for while taking immunosuppressant medications following a kidney transplant."
In an accompanying editorial, Wai Lim, PhD (University of Western Australia) and Steven Chadban, PhD (University of Sydney) noted that "the epidemiologic insights provided by Yanik et al. may have important implications for the pathogenesis and mechanism of cancer development in patients."
The study will be published in an upcoming issue of the Journal of the American Society of Nephrology (JASN).
Source: Newswise
Increased Meat Consumption Linked To Elevated Risk For Kidney Cancer
Reducing consumption of meat, especially meat cooked at high temperatures or over an open flame can lower the risk for kidney cancer.
Advertisement
 Two New Drugs Show Potential to Increase Survival Rates in Kidney Cancer PatientsKidney cancer is a common cancer and once the tumor has spread to other parts of the body only one-in-10 people live for five years after diagnosis. | Advertisement
|
Advertisement
Recommended Reading
Latest Cancer News
A nanoengineering platform targets neutrophils, the white blood cells without killing pancreatic cancer cells paving the way for effective treatments.
The survival rates between lobectomy and wedge resection surgical procedures were found to be the same among lung cancer patients.
The mechanism by which the kinases cause inflammation has been discovered by scientists.
Pancreatic cancer cases are on the rise. The biomarker approach could reduce the chance of developing pancreatic cancer.
New combination of medications trametinib and entinostat were found to decrease lung cancer in mice.